slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 98,761-98,790
Pages 3,950
Rows per page 30
Component
98,761-98,790 of 118,471
01
The slide features both the Aeglea and Spyre Therapeutics logos, indicating a transition or merger context.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
04
Includes a footnote regarding a 1-for-25 reverse stock split.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
24
The slide uses a bar chart to show benchmark data alongside a specific exposure-response analysis for vedolizumab.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
35
The slide uses two distinct chart types: a dose-response curve (sigmoidal) and a scatter plot to demonstrate potency and specificity.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
39
The slide uses a biological process diagram to illustrate the mechanism of action for three distinct drug candidates.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
43
The slide uses a visual representation of a bispecific or combination antibody structure.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
48
The slide uses a table-based timeline structure to map drug candidates (SPY001-004) against expected clinical milestones.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
53
The slide uses a series of icons to represent different scientific methodologies.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
43
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
01
UBS | Results Presentation Deck | 41 slidesUBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Situation & Context1 hit
08
The slide uses a process flow diagram to illustrate the methodology used for evaluating strategic options.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Before After1 hit
09
The slide uses a comparison frame to contrast the negative outcomes of a standalone scenario with the positive outcomes of full integration.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Before After1 hit
16
The chart uses a waterfall structure to show the progression from current state to 2026 exit rate via four strategic levers.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
17
UBS | Results Presentation Deck | 41 slidesUBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Before After1 hit
22
The chart shows the reduction of drawn SNB liquidity facilities over time, highlighting the repayment of higher-cost facilities.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
24
Excludes Credit Suisse; includes footnote regarding seasonal tax payments.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Maturity Curve1 hit
30
The slide uses a waterfall bridge to explain the transition from a negative 2Q23 PBT to a projected break-even/positive state.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Solution & Approach1 hit
31
UBS | Results Presentation Deck | 41 slidesUBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Solution & Approach1 hit
01
Vivid Seats | Investor Presentation Deck | 22 slidesVivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations 1 hit
03
This is a cover or introductory slide for the Vivid Seats pitch deck.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations 1 hit
22
The table includes both absolute dollar values (in thousands) and percentage margins for each line item.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations 1 hit
01
Vivid Seats | Results Presentation Deck | 19 slidesVivid Seats | Results Presentation Deck | 19 slides · Vivid Seats
Conference presentation Investor relations 1 hit
04
Vivid Seats | Results Presentation Deck | 19 slidesVivid Seats | Results Presentation Deck | 19 slides · Vivid Seats
Conference presentation Investor relations Beat · Problem1 hit
07
Vivid Seats | Results Presentation Deck | 19 slidesVivid Seats | Results Presentation Deck | 19 slides · Vivid Seats
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
Vivid Seats | Results Presentation Deck | 19 slidesVivid Seats | Results Presentation Deck | 19 slides · Vivid Seats
Conference presentation Investor relations Beat · TeamLoop · Why Now1 hit
15
Vivid Seats | Results Presentation Deck | 19 slidesVivid Seats | Results Presentation Deck | 19 slides · Vivid Seats
Conference presentation Investor relations 1 hit
16
The slide explains the dual-class structure (Class A and Class B) and how they relate to economic interest and EPS calculations.Vivid Seats | Results Presentation Deck | 19 slides · Vivid Seats
Conference presentation Investor relations 1 hit
19
The table provides a breakdown of various adjustments including tax, interest, D&A, transaction costs, and equity-based compensation, with detailed footnotes explaining each line item.Vivid Seats | Results Presentation Deck | 19 slides · Vivid Seats
Conference presentation Investor relations 1 hit
01
Yatsen | Results Presentation Deck | 17 slidesYatsen | Results Presentation Deck | 17 slides · Yatsen Holding Limited
Conference presentation Investor relations 1 hit
08
The slide highlights the growth of the skincare segment, showing both absolute revenue and percentage contribution to the total.Yatsen | Results Presentation Deck | 17 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit